Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Syndax Pharmaceuticals (SNDX) Receivables - Net (2024 - 2025)

Syndax Pharmaceuticals (SNDX) has 2 years of Receivables - Net data on record, last reported at $38.0 million in Q4 2025.

  • For Q4 2025, Receivables - Net rose 399.82% year-over-year to $38.0 million; the TTM value through Dec 2025 reached $38.0 million, up 399.82%, while the annual FY2025 figure was $38.0 million, 399.82% up from the prior year.
  • Receivables - Net reached $38.0 million in Q4 2025 per SNDX's latest filing, up from $25.4 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $38.0 million in Q4 2025 and bottomed at $7.6 million in Q4 2024.